摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-amino-N-(4-methylthiazol-2-yl)-5-(phenylthio)benzamide | 1146340-39-7

中文名称
——
中文别名
——
英文名称
2-amino-N-(4-methylthiazol-2-yl)-5-(phenylthio)benzamide
英文别名
2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-phenylsulfanylbenzamide
2-amino-N-(4-methylthiazol-2-yl)-5-(phenylthio)benzamide化学式
CAS
1146340-39-7
化学式
C17H15N3OS2
mdl
——
分子量
341.458
InChiKey
PRUWOCJLEGVIOI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    23
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    122
  • 氢给体数:
    2
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    N-(4-methylthiazol-2-yl)-2-nitro-5-(phenylthio)benzamide 在 铁粉氯化铵 作用下, 以 异丙醇 为溶剂, 生成 2-amino-N-(4-methylthiazol-2-yl)-5-(phenylthio)benzamide
    参考文献:
    名称:
    Identification of novel and potent 2-amino benzamide derivatives as allosteric glucokinase activators
    摘要:
    The identification and structure-activity-relationships (SARs) of novel 2-amino benzamide glucokinase activators are described. Compounds in this series were developed to be potent GK activators, and their binding mode to the GK protein was determined by crystal structure analysis. In vivo pharmacokinetic and acute in vivo efficacy studies of compound 18 are also described.
    DOI:
    10.1016/j.bmcl.2009.01.053
点击查看最新优质反应信息

文献信息

  • Identification of novel and potent 2-amino benzamide derivatives as allosteric glucokinase activators
    作者:Teruyuki Nishimura、Tomoharu Iino、Morihiro Mitsuya、Makoto Bamba、Hitomi Watanabe、Daisuke Tsukahara、Kenji Kamata、Kaori Sasaki、Sumika Ohyama、Hideka Hosaka、Mayumi Futamura、Yasufumi Nagata、Jun-ichi Eiki
    DOI:10.1016/j.bmcl.2009.01.053
    日期:2009.3
    The identification and structure-activity-relationships (SARs) of novel 2-amino benzamide glucokinase activators are described. Compounds in this series were developed to be potent GK activators, and their binding mode to the GK protein was determined by crystal structure analysis. In vivo pharmacokinetic and acute in vivo efficacy studies of compound 18 are also described.
查看更多